Approval · Notice of Compliance 25757 · 2021
VYXEOS: Notice of Compliance 25757
Issued April 29, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25757
- Date
- April 29, 2021
- Company
- Jazz Pharmaceuticals Ireland LimitedDublin, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VYXEOS | 02515490 | Marketed |
Medicinal ingredients
- CYTARABINE 100 MG per VIAL
- DAUNORUBICIN 44 MG per VIAL